Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells

다국어 초록 (Multilingual Abstract)

The gene encoding β-catenin is frequently mutated in hepatocellular carcinoma cells. While the oncogenicity of β-catenin has been extensively studied, β-catenin’s role in hepatocellular carcinoma tumor metabolism is currently less well understood. In this study, we found that β-catenin regulates the expression of glutamine synthetase and triggers a series of metabolic changes leading to induction of autophagy in hepatocellular carcinoma cells. β-Catenin-active Hep3B and HepG2 cells exhibited higher basal levels of autophagic activity than did β-catenin wild-type cells. We also found that autophagy in β-catenin-active cells was mediated by glutamine synthetase, as silencing of glutamine synthetase significantly reduced autophagic activity. We also showed that β-catenin-active hepatocellular carcinoma cells were more sensitive to sorafenib than were β-catenin wild-type cells.
Our results demonstrated that glutamine synthetase-mediated autophagy explains the high sensitivity of β-catenin-active hepatocellular carcinoma cells to sorafenib. Our results highlight the importance of glutamine metabolism in the regulation of autophagy in hepatocellular carcinoma cells. More importantly, our study unravels the molecular mechanisms leading to sorafenib sensitivity in hepatocellular carcinoma.

참고문헌 (Reference)

1 Jungermann K, "Zonation of parenchymal and nonparenchymal metabolism in liver" 16 : 179-203, 1996

2 Shi YH, "Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stressrelated apoptosis" 7 : 1159-1172, 2011

3 Llovet JM, "Sorafenib in advanced hepatocellular carcinoma" 359 : 378-390, 2008

4 de La Coste A, "Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas" 95 : 8847-8851, 1998

5 Marino G, "Self-consumption:the interplay of autophagy and apoptosis" 15 : 81-94, 2014

6 El-Serag HB, "Rising incidence of hepatocellular carcinoma in the United States" 340 : 745-750, 1999

7 Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays" 65 : 55-63, 1983

8 Hakvoort TB, "Pivotal role of glutamine synthetase in ammonia detoxification" 65 : 281-293, 2017

9 Minguez B, "Pathogenesis of hepatocellular carcinoma and molecular therapies" 25 : 186-194, 2009

10 Elgendy M, "Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival" 42 : 23-35, 2011

11 Cadoret A, "New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism" 21 : 8293-8301, 2002

12 van der Vos KE, "Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy" 14 : 829-837, 2012

13 Prieto-Dominguez N, "Modulation of autophagy by sorafenib: effects on treatment response" 7 : 151-, 2016

14 Bruix J, "Management of hepatocellular carcinoma" 42 : 1208-1236, 2005

15 Burke ZD, "Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism" 136 : 2316-2324, 2009

16 Kabeya Y, "LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing" 19 : 5720-5728, 2000

17 El-Serag HB, "Hepatocellular carcinoma" 365 : 1118-1127, 2011

18 Cabibbo G, "Hepatocellular cancer: optimal strategies for screening and surveillance" 27 : 142-147, 2009

19 Gebhardt R, "Hepatic autophagy is differentially regulated in periportal and pericentral zones - a general mechanism relevant for other tissues?" 11 : 21-, 2013

20 Dal Bello B, "Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation" 16 : 2157-2166, 2010

21 Mao TL, "Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis" 193 : 95-101, 2001

22 Cheng AL, "Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebocontrolled trial" 10 : 25-34, 2009

23 Hart LS, "ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth" 122 : 4621-4634, 2012

24 White E, "Deconvoluting the context-dependent role for autophagy in cancer" 12 : 401-410, 2012

25 Lock R, "Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation" 22 : 165-178, 2011

26 Benhamouche S, "Apc tumor suppressor gene is the 'zonation-keeper' of mouse liver" 10 : 759-770, 2006

27 Guo JY, "Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis" 25 : 460-470, 2011

28 Park SY, "AMPK interacts with beta-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment" 35 : 1566-1572, 2016